HSP(90)
PET
cancer
fluorine-18
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Feb 2021
01 Feb 2021
Historique:
received:
04
08
2020
revised:
03
11
2020
accepted:
11
11
2020
pubmed:
23
11
2020
medline:
22
6
2021
entrez:
22
11
2020
Statut:
ppublish
Résumé
With the ambition of improving the management of pancreatic neuroendocrine tumors (P-NETs), we developed and preliminary validated a novel fluorine-18 labelled HSP A precursor containing methoxymethyl ethers protecting groups and a tosyl as leaving group was synthesized. The target compound was labeled with nucleophilic The precursor was successfully synthesized and utilized in the Despite the unfavorable in vivo properties of the tracer, the promising results from in vitro autoradiography experiments in frozen sections of P-NETs from surgical resection encourage us to continue the project aiming the improvement of in vivo properties of the tracer.
Identifiants
pubmed: 33221456
pii: S0928-0987(20)30435-8
doi: 10.1016/j.ejps.2020.105647
pii:
doi:
Substances chimiques
Fluorine Radioisotopes
0
Ligands
0
Radiopharmaceuticals
0
Fluorides
Q80VPU408O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105647Informations de copyright
Copyright © 2020. Published by Elsevier B.V.